120 related articles for article (PubMed ID: 25582534)
1. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.
Guitart J; Martinez-Escala ME; Deonizio JM; Gerami P; Kadin ME
J Am Acad Dermatol; 2015 Mar; 72(3):508-15. PubMed ID: 25582534
[TBL] [Abstract][Full Text] [Related]
2. Epidermal pseudocarcinomatous hyperplasia with underlying epidermal growth factor-producing cutaneous CD30-positive lymphoproliferative disorder.
Kawachi Y; Taguchi S; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):181-3. PubMed ID: 18429982
[No Abstract] [Full Text] [Related]
3. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
Lin JH; Lee JY
J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
[TBL] [Abstract][Full Text] [Related]
6. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
7. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
[TBL] [Abstract][Full Text] [Related]
8. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
[TBL] [Abstract][Full Text] [Related]
9. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
[TBL] [Abstract][Full Text] [Related]
11. Acquired ichthyosis associated with primary cutaneous CD30+ lymphoproliferative disorders.
López Aventín D; Gallardo F; Yébenes M; Lloreta J; Pujol RM
Eur J Dermatol; 2014; 24(1):105-6. PubMed ID: 24491290
[No Abstract] [Full Text] [Related]
12. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
13. CD30+ cell population in common keratoacanthomas: a study of 21 cases.
Fernandez-Flores A
Rom J Morphol Embryol; 2008; 49(2):159-62. PubMed ID: 18516321
[TBL] [Abstract][Full Text] [Related]
14. Pseudocarcinomatous Hyperplasia Hiding Lymphomatoid Papulosis: A "Low-Power View" Pitfall.
Bellafiore S; Grenzi L; Simonetti V; Piana S
Int J Surg Pathol; 2016 May; 24(3):232-6. PubMed ID: 26711583
[TBL] [Abstract][Full Text] [Related]
15. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
17. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
Price A; Miller JH; Junkins-Hopkins JM
J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
[TBL] [Abstract][Full Text] [Related]
18. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
[TBL] [Abstract][Full Text] [Related]
19. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
[TBL] [Abstract][Full Text] [Related]
20. CD30+ lymphoproliferative disorders of the skin: still an open question.
Alaibac M; Zarian H; Russo I; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]